A link between immune hyperactivation of T cells during HIV-1 infection and the virus protease?

AIDS

Volumn 20, Issue 5, 2006, Pages 769-771

  Chiodi, Francesca ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CD4 T cell decline; HIV 1 fitness; HIV 1 protease; Protease inhibitors; T cell hyperactivation

Indexed keywords

EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIREMIA; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTIGENS, CD38; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HIV PROTEASE; HIV-1; HLA-DR ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; VIREMIA; VIRUS REPLICATION;

EID: 33745087778     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000216378.84313.b6     Document Type: Editorial

References (18)

1. Effros RB, Allsopp R, Chiu CP, Hausner MA, Hirji K, Wang L, et al. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996; 10:F17-F22.
2. Rethi B, Fluur C, Atlas A, Krzyzowska M, Mowafi F, Grützmeier S, et al. Loss of IL-7Rα is associated with CD4+ T cell depletion, high IL-7 levels and CD28 down-regulation in HIV infected patients. AIDS 2005; 19:2077-2086.
3. Hazenberg MD, Otto SA, van Benthem BHB, Roos MTL, Coutinho RA, Lange JMA, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003; 17:1881-1888.
4. Deeks SC, Kitchen CMR, Liu L, Guo H, Gascon R, Narväez AB, et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T cell changes indipendent of viral load. Blood 2004; 104:942-947.
5. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003; 187:1534-1543.
6. Hazenberg MD, Stuart JWT, Otto SA, Borleffs JCC, Boucher CAB, de Boer RJ, et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 2000; 95:249-255.
7. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277:112-116.
8. De Milito A, Hejdeman B, Albert J, Aleman S, Sonnerborg A, Zazzi M, et al. High plasma levels of soluble Fas in HIV type 1-infected subjects are not normalized during highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2000; 16:1379-1384.
9. Hazenberg MD, Otto SA, Stuart JWT, Verschuren MCM, Borleffs JCC, Boucher CAB, et al. Increased cell division but nor thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naïve T cell population in HIV-1 infection. Nat Med 2000; 6:1036-1042.
10. Hazenberg MD, Hamann D, Schuitemaker H, Miedema F. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol 2000; 1:285-289.
11. Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005; 5:783-792.
12. Barbour JD, Wrin T, Grant RM, Martin JN, Segal MR, Petropoulos CJ, et al. Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults. J Virol 2002; 76:11104-11112.
13. Barbour JD, Hecht FM, Wrin T, Segal MR, Ramstead CA, Liegler TJ, et al. Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naïve adults in early HIV-1 infection. J Infect Dis 2004; 190:251-256.
14. Deeks SG, Hoh R, Neilands TB, Liegler T, Aweeka F, Petropoulos CJ, et al. Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection. J Infect Dis 2005; 192:1537-1544.
15. Alatrakchi N, Duvivier C, Costagliola D, Samri A, Marcelin AG, Kamkamidze G, et al. Persistent low viral load on antiretroviral therapy is associated with T-cell mediated control of HIV replication. AIDS 2005; 19:25-33.
16. Simon V, Padte N, Murray D, Vanderhoeven J, Wrin T, Parkin N, et al. Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infection. J Virol 2003; 77:7736-7745.
17. Titanji K, Chiodi F, Bellocco R, Schepis D, Osorio L, Tassandin C, et al. The B lymphocyte pool during primary HIV-1 infection and effects of early antiretroviral therapy on humoral immunity. AIDS 2005; 19:1947-1955.
18. De Milito A, Nilsson A, Titanji K, Thorstensson R, Reizenstein E, Narita M, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004; 103:2180-2186.